SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-001755
Filing Date
2024-01-24
Accepted
2024-01-24 16:40:39
Documents
1
Period of Report
2024-01-22

Document Format Files

Seq Description Document Type Size
1 form4-01242024_090133.html 4  
1 form4-01242024_090133.xml 4 4906
  Complete submission text file 0001415889-24-001755.txt   6444
Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SANGAMO THERAPEUTICS, INC. 7000 MARINA BOULEVARD BRISBANE CA 94005
Business Address
Dubois-Stringfellow Nathalie (Reporting) CIK: 0001947007 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30171 | Film No.: 24556977